HCP Targeting Report

Accurately Identify Patients and Their HCPs, Even for Rare and Hard-to-Diagnose Conditions

MMIT’s HCP and Patient Targeting Solution is powered by NorstellaLinQ, the industry’s first and only fully integrated data asset created by MMIT’s parent company Norstella.

Using structured and unstructured data like electronic medical records, open and closed claims, and lab orders and results, we help you pinpoint hard-to-reach patients and their treating providers.

Learn More

Patient Finding

Identify patients and their treating providers at the right time in the patient journey.

Market Sizing

Understand the true prevalence of rare and hard-to-diagnose conditions.

Risk Stratification

Hyper-segment patients using clinical notes, lab results and other real-world data.

Patient Journey

Correlate treatment patterns with HCP sentiment and behavior, payer coverage, site-of-care trends and other factors.

How We Help

icon

NorstellaLinQ brings together open and closed claims, lab results, electronic medical records, and payer intelligence data.

icon

Our tech, data, clinical, and pharma experts tailor the data to your needs to ensure success.

icon

Our harmonized, linked, longitudinal data is ready to use.

icon

Outputs can be delivered in a tailored solution that meets your needs.

Keep Up-to-Date with Key Insights From MMIT

norstellalinq

NorstellaLinQ

The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in commercialization.

LEARN MORE ABOUT NORSTELLALINQ
rwd-use-case-ebook

Data That Delivers: Real-World Insights in Action

See how MMIT, powered by NorstellaLinQ, is helping manufacturers understand the full patient journey by downloading our latest ebook.

ACCESS THE EBOOK
complex-cohort-identification-fuels-real-time-hcp-targeting

Complex Cohort Identification Fuels Real-Time HCP Targeting

Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.

ACCESS THE USE CASE
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch